Hepatitis b virus lacks immune activating capacity, but actively inhibits plasmacytoid dendritic cell function

PLoS ONE

Volumn 6, Issue 1, 2011, Pages

  Woltman, Andrea M ^a   den Brouw, Marjoleine L Op ^a   Biesta, Paula J ^a   Shi, Cui C ^a,b   Janssen, Harry L A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 6; PROTEIN S6; TUMOR NECROSIS FACTOR ALPHA; VIRUS PROTEIN;

ADULT; ARTICLE; CELL FUNCTION; CELL INTERACTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EX VIVO STUDY; FEMALE; GENETIC TRANSCRIPTION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNOREGULATION; IN VITRO STUDY; MALE; MONOCYTE; NATURAL KILLER CELL; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PROTEIN PHOSPHORYLATION; UPREGULATION; BIOSYNTHESIS; CASE CONTROL STUDY; CELL COMMUNICATION; CELL CULTURE; DENDRITIC CELL; GENETICS; IMMUNITY; IMMUNOLOGY; VIROLOGY;

ANIMALIA; HEPATITIS B VIRUS;

CASE-CONTROL STUDIES; CELL COMMUNICATION; CELLS, CULTURED; DENDRITIC CELLS; HEPATITIS B VIRUS; HUMANS; IMMUNITY; MONOCYTES; TUMOR NECROSIS FACTOR-ALPHA; VIRAL PROTEINS;

EID: 79251543296     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0015324     Document Type: Article

References (39)

1. Ganem D, Prince AM (2004) Hepatitis B virus infection-natural history andclinical consequences. N Engl J Med 350: 1118-1129.
2. Rehermann B, Nascimbeni M (2005) Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 5: 215-229.
3. Boonstra A, Woltman AM, Janssen HL (2008) Immunology of hepatitis B and hepatitis C virus infections. Best Pract Res Clin Gastroenterol 22: 1049-1061.
4. Garcia-Sastre A, Biron CA (2006) Type 1 interferons and the virus-host relationship: a lesson in detente. Science 312: 879-882.
5. Wieland S, Thimme R, Purcell RH, Chisari FV (2004) Genomic analysis of the host response to hepatitis B virus infection. Proc Natl Acad Sci U S A 101: 6669-6674.
6. Dunn C, Peppa D, Khanna P, Nebbia G, Jones M, et al. (2009) Temporal analysis of early immune responses in patients with acute hepatitis B virus infection. Gastroenterology 137: 1289-1300.
7. Colonna M, Trinchieri G, Liu YJ (2004) Plasmacytoid dendritic cells in immunity. Nat Immunol 5: 1219-1226.
8. Gilliet M, Cao W, Liu YJ (2008) Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat Rev Immunol 8: 594-606.
9. Ito T, Wang YH, Liu YJ (2005) Plasmacytoid dendritic cell precursors/type I interferon-producing cells sense viral infection by Toll-like receptor (TLR) 7 and TLR9. Springer Semin Immunopathol 26: 221-229.
10. Kawai T, Akira S (2006) Innate immune recognition of viral infection. Nat Immunol 7: 131-137.
11. Della Chiesa M, Sivori S, Castriconi R, Marcenaro E, Moretta A (2005) Pathogen-induced private conversations between natural killer and dendritic cells. Trends Microbiol 13: 128-136.
12. Della Chiesa M, Romagnani C, Thiel A, Moretta L, Moretta A (2006) Multidirectional interactions are bridging human NK cells with plasmacytoid and monocyte-derived dendritic cells during innate immune responses. Blood 108: 3851-3858.
13. Woltman AM, Boonstra A, Janssen HL (2010) Dendritic cells in chronic viral hepatitis B and C: victims or guardian angels? Gut 59: 115-125.
14. Xu Y, Hu Y, Shi B, Zhang X, Wang J, et al. (2009) HBsAg inhibits TLR9- mediated activation and IFN-alpha production in plasmacytoid dendritic cells. Mol Immunol 46: 2640-2646.
15. van der Molen RG, Sprengers D, Binda RS, de Jong EC, Niesters HG, et al. (2004) Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B. Hepatology 40: 738-746.
16. Tavakoli S, Mederacke I, Herzog-Hauff S, Glebe D, Grun S, et al. (2008) Peripheral blood dendritic cells are phenotypically and functionally intact in chronic hepatitis B virus (HBV) infection. Clin Exp Immunol 151: 61-70.
17. Fanning SL, George TC, Feng D, Feldman SB, Megjugorac NJ, et al. (2006) Receptor cross-linking on human plasmacytoid dendritic cells leads to the regulation of IFN-alpha production. J Immunol 177: 5829-5839.
18. Seeger C, Mason WS (2000) Hepatitis B virus biology. Microbiol Mol Biol Rev 64: 51-68.
19. Cao W, Manicassamy S, Tang H, Kasturi SP, Pirani A, et al. (2008) Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3)K-mTOR-p70S6K pathway. Nat Immunol 9: 1157-1164.
20. Chung J, Kuo CJ, Crabtree GR, Blenis J (1992) Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases. Cell 69: 1227-1236.
21. Cao W, Rosen DB, Ito T, Bover L, Bao M, et al. (2006) Plasmacytoid dendritic cell-specific receptor ILT7-Fc epsilonRI gamma inhibits Toll-like receptorinduced interferon production. J Exp Med 203: 1399-1405.
22. Oliviero B, Varchetta S, Paudice E, Michelone G, Zaramella M, et al. (2009) Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections. Gastroenterology 137: 1151-1160.
23. Tjwa ETTL, Van Oord GW, Hegmans JP, Janssen HLA, Woltman AM. Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B. J Hepatol in press.
24. Wu J, Lu M, Meng Z, Trippler M, Broering R, et al. (2007) Toll-like receptormediated control of HBV replication by nonparenchymal liver cells in mice. Hepatology 46: 1769-1778.
25. Wu J, Meng Z, Jiang M, Pei R, Trippler M, et al. (2009) Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells. Hepatology 49: 1132-1140.
26. Hosel M, Quasdorff M, Wiegmann K, Webb D, Zedler U, et al. (2009) Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection. Hepatology 50: 1773-1782.
27. Glebe D, Urban S (2007) Viral and cellular determinants involved in hepadnaviral entry. World J Gastroenterol 13: 22-38.
28. Op den Brouw ML, Binda RS, van Roosmalen MH, Protzer U, Janssen HL, et al. (2009) Hepatitis B virus surface antigen impairs myeloid dendritic cell function: a possible immune escape mechanism of hepatitis B virus. Immunology 126: 280-289.
29. Op den Brouw ML, Binda RS, Geijtenbeek TB, Janssen HL, Woltman AM (2009) The mannose receptor acts as hepatitis B virus surface antigen receptor mediating interaction with intrahepatic dendritic cells. Virology 393: 84-90.
30. Meyer-Wentrup F, Benitez-Ribas D, Tacken PJ, Punt CJ, Figdor CG, et al. (2008) Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-alpha production. Blood 111: 4245-4253.
31. Liu B, Woltman AM, Janssen HL, Boonstra A (2009) Modulation of dendritic cell function by persistent viruses. J Leukoc Biol 85: 205-214.
32. Xie Q, Shen HC, Jia NN, Wang H, Lin LY, et al. (2009) Patients with chronic hepatitis B infection display deficiency of plasmacytoid dendritic cells with reduced expression of TLR9. Microbes Infect 11: 515-523.
33. Duan XZ, Wang M, Li HW, Zhuang H, Xu D, Wang FS (2004) Decreased frequency and function of circulating plasmocytoid dendritic cells (pDC) in hepatitis B virus infected humans. J Clin Immunol 24: 637-646.
34. van der Molen RG, Sprengers D, Biesta PJ, Kusters JG, Janssen HLA (2006) Favorable effect of adefovir on the number and functionality of myeloid dendritic cells of patients with chronic HBV. Hepatology 44: 907-914.
35. Chen M, Sallberg M, Hughes J, Jones J, Guidotti LG, et al. (2005) Immune tolerance split between hepatitis B virus precore and core proteins. J Virol 79: 3016-3027.
36. Vanlandschoot P, Van Houtte F, Roobrouck A, Farhoudi A, Leroux-Roels G (2002) Hepatitis B virus surface antigen suppresses the activation of monocytes through interaction with a serum protein and a monocyte-specific receptor. J Gen Virol 83: 1281-1289.
37. McHutchison JG, Bacon BR, Gordon SC, Lawitz E, Shiffman M, et al. (2007) Phase 1B, randomized, double-blind, dose-escalation trial of CPG 10101 in patients with chronic hepatitis C virus. Hepatology 46: 1341-1349.
38. Op den Brouw ML, de Jong MA, Ludwig IS, van der Molen RG, Janssen HLA, et al. (2008) Branched oligosaccharide structures on HBV prevent interaction with both DC-SIGN and L-SIGN. J Viral Hepat 15: 675-683.
39. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.